Long-term analysis of multimodality treatment outcomes and prognosis of esthesioneuroblastomas: a single center results of 138 patients

被引:0
作者
Meng Sun
Kai Wang
Yuan Qu
Jianghu Zhang
Shiping Zhang
Xuesong Chen
Jingbo Wang
Runye Wu
Ye Zhang
Junlin Yi
Jianping Xiao
Guozhen Xu
Xiaodong Huang
Jingwei Luo
机构
[1] National Cancer Center/ National Clinical Research Center for Cancer/Cancer Hospital,Department of Radiation Oncology
[2] Chinese Academy of Medical Sciences and Peking Union Medical College,undefined
来源
Radiation Oncology | / 15卷
关键词
Esthesioneuroblastoma; Treatment strategy; Survival outcomes; Prognostic factors;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 79 条
[1]  
Broich G(1997)Esthesioneuroblastoma: a general review of the cases published since the discovery of the tumour in 1924 Anticancer Res 17 2683-2706
[2]  
Pagliari A(2007)Esthesioneuroblastoma: a population-based analysis of survival and prognostic factors Arch Otolaryngol Head Neck Surg 133 276-280
[3]  
Ottaviani F(2002)Esthesioneuroblastoma: clinical presentation, radiological, and pathological features, treatment, review of the literature, and the University of Virginia experience Neurosurg Focus 12 e4-421
[4]  
Jethanamest D(1924)L’esthesioneuroepitheliome olfactif Bull Assoc Fr Etude Cancer 13 410-1576
[5]  
Morris LG(1976)Olfactory neuroblastoma. A clinical analysis of 17 cases Cancer. 37 1571-53
[6]  
Sikora AG(2016)Long-term outcomes of patients with esthesioneuroblastomas: a cohort from a single institution Oral Oncol 53 48-947
[7]  
Oskouian RJ(2018)Esthesioneuroblastoma: a patterns-of-care and outcomes analysis of the national Cancer database Neurosurgery. 83 940-530
[8]  
Jane JA(2011)Improved survival following surgery and radiation therapy for olfactory neuroblastoma: analysis of the SEER database Radiat Oncol 6 41-834
[9]  
Dumont AS(2014)Optimization of long-term outcomes for patients with esthesioneuroblastoma Head Neck. 36 524-59
[10]  
Berger L(2020)Prognostic factors and outcomes of multimodality treatment in olfactory neuroblastoma Oral Oncol 103 104618-181